Literature DB >> 26697844

p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism.

Savitha S Sharma1, Le Ma1, W Jackson Pledger1,2.   

Abstract

The cyclin-dependent kinase (CDK) inhibitor p27Kip1 has been shown to regulate cellular proliferation via inhibition of CDK activities. It is now recognized that p27Kip1 can regulate cellular processes through non-canonical, CDK-independent mechanisms. We have developed an inducible p27Kip1 model in cultured cells to explore CDK-independent p27Kip1 regulation of biological processes. We present evidence that p27Kip1 can function in a CDK-independent manner to inhibit entry and/or progression of S phase. Even though this p27Kip1 mechanism is non-canonical it does requires the intact cyclin-binding motif in p27Kip1. We suggest a mechanism similar to that proposed in post-mitotic neural cells whereby p27Kip1 functions to coordinate growth arrest and apoptosis. Our hypothesis supports the concept that p27Kip1 is a gatekeeper for the entry and progression of S phase through interaction with specific protein(s) or via binding to specific DNA sequences in a CDK-independent manner.

Entities:  

Keywords:  cell cycle; cyclin F; cyclin-dependent kinases; non-canonical; p27Kip1

Mesh:

Substances:

Year:  2015        PMID: 26697844      PMCID: PMC4825794          DOI: 10.1080/15384101.2015.1100775

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Cip/Kip proteins: more than just CDKs inhibitors.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

2.  The cyclin-dependent kinase inhibitor SCH 727965 (dinacliclib) induces the apoptosis of osteosarcoma cells.

Authors:  Wei Fu; Le Ma; Baoky Chu; Xue Wang; Marilyn M Bui; Jennifer Gemmer; Soner Altiok; W Jackson Pledger
Journal:  Mol Cancer Ther       Date:  2011-04-13       Impact factor: 6.261

3.  Nucleocytoplasmic Cdk5 is involved in neuronal cell cycle and death in post-mitotic neurons.

Authors:  Jie Zhang; Karl Herrup
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

Review 4.  p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.

Authors:  Seth A Wander; Dekuang Zhao; Joyce M Slingerland
Journal:  Clin Cancer Res       Date:  2010-10-21       Impact factor: 12.531

5.  p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.

Authors:  R Pippa; L Espinosa; G Gundem; R García-Escudero; A Dominguez; S Orlando; E Gallastegui; C Saiz; A Besson; M J Pujol; N López-Bigas; J M Paramio; A Bigas; O Bachs
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

6.  Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.

Authors:  Giuseppe Viglietto; Maria Letizia Motti; Paola Bruni; Rosa Marina Melillo; Amelia D'Alessio; Daniela Califano; Floriana Vinci; Gennaro Chiappetta; Philip Tsichlis; Alfonso Bellacosa; Alfredo Fusco; Massimo Santoro
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

7.  p27Kip1 modulates cell migration through the regulation of RhoA activation.

Authors:  Arnaud Besson; Mark Gurian-West; Anja Schmidt; Alan Hall; James M Roberts
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

8.  Cyclin F disruption compromises placental development and affects normal cell cycle execution.

Authors:  Michael T Tetzlaff; Chang Bai; Milton Finegold; John Wilson; J Wade Harper; Kathleen A Mahon; Stephen J Elledge
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

9.  A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation.

Authors:  S S Sharma; L Ma; T K Bagui; K D Forinash; W J Pledger
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

10.  Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer.

Authors:  S Wen; Y So; K Singh; J M Slingerland; M B Resnick; S Zhang; V Ruiz; S F Moss
Journal:  Oncogene       Date:  2011-08-15       Impact factor: 9.867

View more
  4 in total

Review 1.  The non-canonical functions of p27(Kip1) in normal and tumor biology.

Authors:  Savitha S Sharma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2016-04-15       Impact factor: 4.534

2.  miR-429 Inhibits Differentiation and Promotes Proliferation in Porcine Preadipocytes.

Authors:  Ying Peng; Fen-Fen Chen; Jing Ge; Jia-Yu Zhu; Xin-E Shi; Xiao Li; Tai-Yong Yu; Gui-Yan Chu; Gong-She Yang
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

3.  Sumoylation in p27kip1 via RanBP2 promotes cancer cell growth in cholangiocarcinoma cell line QBC939.

Authors:  Jun Yang; Yan Liu; Bing Wang; Hongzhen Lan; Ying Liu; Fei Chen; Ju Zhang; Jian Luo
Journal:  BMC Mol Biol       Date:  2017-09-07       Impact factor: 2.946

4.  Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells.

Authors:  Haena Moon; Seong Gak Jeon; Jin-Il Kim; Hyeon Soo Kim; Sangho Lee; Dongok Kim; Seungjoon Park; Minho Moon; Hyunju Chung
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.